search

Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A486–A487, https://doi.org/10.1210/jendso/bvac150.1010

Published: 01 November 2022

Journal Article

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome

PDF

Sanjay Jumani and others

in Journal of the Endocrine Society

Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A849–A850, https://doi.org/10.1210/jendso/bvac150.1756

Published: 01 November 2022

Journal Article

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation

PDF

Diana Grace Varghese and others

in Journal of the Endocrine Society

Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A538, https://doi.org/10.1210/jendso/bvac150.1119

Published: 01 November 2022

Journal Article

Fracture Risk in Pediatric Patients With MEN2B

PDF

Iris Li and others

in The Journal of Clinical Endocrinology & Metabolism

The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 12, December 2022, Pages e4371–e4378, https://doi.org/10.1210/clinem/dgac500

Published: 03 September 2022

2 3

Modify your search

Availability

NARROW

Format

Subject

Type

Collection

Journal

Publication date

Approach to the Patient with Metastatic Pheochromocytoma and Paraganglioma Get access

OR16-01 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression

PD15-12 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression

6918 A Unique Case of Oncocytic Thyroid Cancer with an NBN Gene Pathogenic Variant

A review of mitotane in the management of adrenocortical cancer Get access

Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients

International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects Get access

SAT329 Case Series Of Patients With FGFR-1 Related Pheochromocytoma With A Focus On Biochemical And Imaging Signatures

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome

SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors

SAT555 Utility of ¹⁸F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation

Fracture Risk in Pediatric Patients With MEN2B

Modify your search

Publication date

OR16-01 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression Open Access

PD15-12 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression Open Access

6918 A Unique Case of Oncocytic Thyroid Cancer with an NBN Gene Pathogenic Variant Open Access

Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients Open Access

SAT329 Case Series Of Patients With FGFR-1 Related Pheochromocytoma With A Focus On Biochemical And Imaging Signatures Open Access

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome Open Access

SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors Open Access

SAT555 Utility of 18F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B Open Access

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane Open Access

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership Free

Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression Free

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting Free

Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors Free

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors Open Access

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome Open Access

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation Open Access

Fracture Risk in Pediatric Patients With MEN2B Free

This Feature Is Available To Subscribers Only

OR16-01 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression

PD15-12 Single-Nuclei Multiomic Analysis of Small Intestinal Neuroendocrine Tumors and Matched Liver Metastases Reveals Gene Expression Changes Associated With Disease Progression

6918 A Unique Case of Oncocytic Thyroid Cancer with an NBN Gene Pathogenic Variant

Managing Catecholamine Release Syndrome During and Following Lu-177-DOTATATE in High-Risk Pheochromocytoma Patients

SAT329 Case Series Of Patients With FGFR-1 Related Pheochromocytoma With A Focus On Biochemical And Imaging Signatures

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome

SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors

SAT555 Utility of ¹⁸F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation

Fracture Risk in Pediatric Patients With MEN2B